- Home
- BTSG vs AMRX Comparison
BTSG vs AMRX Comparison
Compare BTSG & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTSG
- AMRX
- Stock Information
- Founded
- BTSG 1974
- AMRX 2002
- Country
- BTSG United States
- AMRX United States
- Employees
- BTSG N/A
- AMRX N/A
- Industry
- BTSG
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- BTSG
- AMRX Health Care
- Exchange
- BTSG NYSE
- AMRX Nasdaq
- Market Cap
- BTSG 3.0B
- AMRX 2.4B
- IPO Year
- BTSG 2024
- AMRX N/A
- Fundamental
- Price
- BTSG $18.09
- AMRX $8.38
- Analyst Decision
- BTSG Strong Buy
- AMRX Strong Buy
- Analyst Count
- BTSG 9
- AMRX 5
- Target Price
- BTSG $22.13
- AMRX $10.80
- AVG Volume (30 Days)
- BTSG 1.6M
- AMRX 1.8M
- Earning Date
- BTSG 03-06-2025
- AMRX 05-02-2025
- Dividend Yield
- BTSG N/A
- AMRX N/A
- EPS Growth
- BTSG N/A
- AMRX N/A
- EPS
- BTSG N/A
- AMRX N/A
- Revenue
- BTSG $11,266,472,000.00
- AMRX $2,793,957,000.00
- Revenue This Year
- BTSG $7.77
- AMRX $10.49
- Revenue Next Year
- BTSG $10.64
- AMRX $7.00
- P/E Ratio
- BTSG N/A
- AMRX N/A
- Revenue Growth
- BTSG 27.65
- AMRX 16.73
- 52 Week Low
- BTSG $9.98
- AMRX $5.18
- 52 Week High
- BTSG $24.82
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- BTSG 45.45
- AMRX 46.15
- Support Level
- BTSG $17.64
- AMRX $8.18
- Resistance Level
- BTSG $19.00
- AMRX $8.95
- Average True Range (ATR)
- BTSG 0.75
- AMRX 0.31
- MACD
- BTSG 0.17
- AMRX -0.08
- Stochastic Oscillator
- BTSG 60.74
- AMRX 23.40
About BTSG BRIGHTSPRING HEALTH SERVICES INC
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.